Rendo P - Search Results

1

A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use.

Berntorp E, Keeling D, Makris M, Tagliaferri A, Male C, Mauser-Bunschoten EP, Musso R, Roca CA, Hassoun A, Kollmer C, Charnigo R, Baumann J, Rendo P. Berntorp E, et al. Among authors: rendo p. Haemophilia. 2012 Jul;18(4):503-9. doi: 10.1111/j.1365-2516.2011.02685.x. Epub 2011 Nov 2. Haemophilia. 2012. PMID: 22044794

2

Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B.

Yang R, Zhao Y, Wang X, Sun J, Jin J, Wu D, Charnigo R, O'Brien A, Zhong Z, Rendo P. Yang R, et al. Among authors: rendo p. Haemophilia. 2012 Sep;18(5):e374-8. doi: 10.1111/j.1365-2516.2012.02907.x. Epub 2012 Jul 9. Haemophilia. 2012. PMID: 22776196 Clinical Trial. No abstract available.

3

Clinical experience with moroctocog alfa (AF-CC) in younger paediatric patients with severe haemophilia A: Two open-label studies.

Rusen L, Kavakli K, Korth-Bradley J, Huard F, Rendo P, Fuiman J, Baumann JA, Smith L, Alvey C, Rupon J. Rusen L, et al. Among authors: rendo p. Haemophilia. 2018 Jul;24(4):604-610. doi: 10.1111/hae.13466. Epub 2018 Mar 26. Haemophilia. 2018. PMID: 29582525 Clinical Trial.

4

Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings.

Parra Lopez R, Nemes L, Jimenez-Yuste V, Rusen L, Cid AR, Charnigo RJ, Baumann JA, Smith L, Korth-Bradley JM, Rendo P. Parra Lopez R, et al. Among authors: rendo p. Thromb Haemost. 2015 Oct;114(4):676-84. doi: 10.1160/TH14-09-0760. Epub 2015 Aug 13. Thromb Haemost. 2015. PMID: 26293201 Clinical Trial.

5

Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B.

Kavakli K, Smith L, Kuliczkowski K, Korth-Bradley J, You CW, Fuiman J, Zupančić-Šalek S, Abdul Karim F, Rendo P. Kavakli K, et al. Among authors: rendo p. Haemophilia. 2016 May;22(3):381-8. doi: 10.1111/hae.12878. Epub 2016 Jan 29. Haemophilia. 2016. PMID: 26823276 Clinical Trial.

6

Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects.

Valentino LA, Rusen L, Elezovic I, Smith LM, Korth-Bradley JM, Rendo P. Valentino LA, et al. Among authors: rendo p. Haemophilia. 2014 May;20(3):398-406. doi: 10.1111/hae.12344. Epub 2014 Jan 13. Haemophilia. 2014. PMID: 24418368 Clinical Trial.

7

Assessment of Relative Bioavailability of Moroctocog Alfa and Moroctocog Alfa (AF-CC) in Subjects With Severe Hemophilia A.

Korth-Bradley J, Rupon J, Plotka A, Charnigo R, Rendo P. Korth-Bradley J, et al. Among authors: rendo p. Clin Transl Sci. 2018 May;11(3):283-288. doi: 10.1111/cts.12544. Epub 2018 Mar 25. Clin Transl Sci. 2018. PMID: 29575770 Free PMC article. Clinical Trial.

8

Lack of seasonal variation in bleeding and patient-assessed pain patterns in patients with haemophilia B receiving on-demand therapy.

Shafer F, Smith L, Vendetti N, Rendo P, Carr M. Shafer F, et al. Among authors: rendo p. Haemophilia. 2014 May;20(3):349-53. doi: 10.1111/hae.12305. Epub 2013 Nov 29. Haemophilia. 2014. PMID: 24286226 Free PMC article. Clinical Trial.

9

Pharmacokinetics, Efficacy, and Safety of Nonacog Alfa in Previously Treated Patients with Moderately Severe to Severe Hemophilia B.

Korth-Bradley JM, Rendo P, Smith L, Altisent C. Korth-Bradley JM, et al. Among authors: rendo p. Clin Ther. 2016 Apr;38(4):936-44. doi: 10.1016/j.clinthera.2016.02.015. Epub 2016 Mar 8. Clin Ther. 2016. PMID: 26969334

10

Nonacog alfa: an analysis of safety data from six prospective clinical studies in different patient populations with haemophilia B treated with different therapeutic modalities.

Rendo P, Smith L, Lee HY, Shafer F. Rendo P, et al. Blood Coagul Fibrinolysis. 2015 Dec;26(8):912-8. doi: 10.1097/MBC.0000000000000359. Blood Coagul Fibrinolysis. 2015. PMID: 26196195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters